Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment and care. Thanks to artificial intelligence research conducted at McGill University, this kind of predictive power could soon be available to clinicians everywhere.
Scientists from the Douglas Mental Health University Institute’s Translational Neuroimaging Laboratory at McGill used artificial intelligence techniques and big data to develop an algorithm capable of recognizing the signatures of dementia two years before its onset, using a single amyloid PET scan of the brain of patients at risk of developing Alzheimer’s disease. Their findings appear in a new study published in the journal Neurobiology of Aging.
Dr. Pedro Rosa-Neto, co-lead author of the study and Associate Professor in McGill’s departments of Neurology & Neurosurgery and Psychiatry, expects that this technology will change the way physicians manage patients and greatly accelerate treatment research into Alzheimer’s disease.
“By using this tool, clinical trials could focus only on individuals with a higher likelihood of progressing to dementia within the time frame of the study. This will greatly reduce the cost and the time necessary to conduct these studies,” adds Dr. Serge Gauthier, co-lead author and Professor of Neurology & Neurosurgery and Psychiatry at McGill.
Amyloid as a biomarker of dementia
Scientists have long known that a protein known as amyloid accumulates in the brain of patients with mild cognitive impairment (MCI), a condition that often leads to dementia. Though the accumulation of amyloid begins decades before the symptoms of dementia occur, this protein couldn’t be used reliably as a predictive biomarker because not all MCI patients develop Alzheimer’s disease.
To conduct their study, the McGill researchers drew on data available through the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a global research effort in which participating patients agree to complete a variety of imaging and clinical assessments.
Sulantha Mathotaarachchi, a computer scientist from Rosa-Neto’s and Gauthier’s team, used hundreds of amyloid PET scans of MCI patients from the ADNI database to train the team’s algorithm to identify which patients would develop dementia, with an accuracy of 84%, before symptom onset. Research is ongoing to find other biomarkers for dementia that could be incorporated into the algorithm in order to improve the software’s prediction capabilities.
“This is an example how big data and open science brings tangible benefits to patient care,” says Dr. Rosa-Neto, who is also director of the McGill University Research Centre for Studies in Aging.
While new software has been made available online to scientists and students, physicians won’t be able to use this tool in clinical practice before certification by health authorities. To that end, the McGill team is currently conducting further testing to validate the algorithm in different patient cohorts, particularly those with concurrent conditions such as small strokes.
The Latest on: Predictive medicine using artificial intelligence
- Delivering security and continuity for the cities of tomorrow on December 17, 2018 at 8:45 pm
It’s seems like almost every part of our lives is now being supported by emerging technologies, from predictive analytics and artificial intelligence to the Internet ... so it’s no surprise that the u... […]
- Veritas Predictive Insights uses artificial intelligence and machine learning to predict, prevent unplanned downtime on December 6, 2018 at 12:18 am
Veritas Technologies, the worldwide leader in enterprise data protection and the software-defined storage market, today announced the launch of Veritas Predictive Insights, a new solution that utilise... […]
- Artificial intelligence may fall short when analyzing data across multiple health systems on November 6, 2018 at 11:58 am
Artificial intelligence ... and cheated at their predictive task based on the prevalence of pneumonia at the training institution. Researchers found that the difficulty of using deep learning models i... […]
- Predicting the response to immunotherapy using artificial intelligence on August 27, 2018 at 8:56 am
A study published in The Lancet Oncology establishes for the first time that artificial intelligence ... medicine) have created a so-called radiomic signature. This signature defines the level of lymp... […]
- Artificial intelligence in medicine — predicting patient outcomes and beyond on May 8, 2018 at 9:31 am
Predictive models can help make care better basically by creating winning partnerships in which the machine predicts and the doctor decides on follow-up action. The point of using AI ... issues for ar... […]
- The World of Artificial Intelligence on October 6, 2017 at 2:13 pm
When it comes to applications of Predictive Analytics ... optimizing marketing campaigns) by using data mining, machine learning and AI techniques to analyze current data. All of these different types ... […]
- Artificial intelligence and the coming health revolution on June 19, 2017 at 12:16 am
Artificial intelligence is rapidly moving into health care, led by some of the biggest technology companies and emerging startups using it to diagnose ... University's Langone School of Medicine who l... […]
- How artificial intelligence is revolutionizing healthcare on April 13, 2017 at 1:33 am
One of the most basic yet efficient use cases of artificial intelligence is to optimize the clinical ... The creators believe this will help in creating predictive and preventive treatments. For some ... […]
via Google News and Bing News